Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
53
Sources here
2
Companies here
3
Current section Argentina Medical Devices news
Latest

finance.yahoo.com Guidance

Philips (ENXTAM:PHIA) Expands Open Monitoring Ecosystem And Launches Postpartum Support Tool

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Koninklijke Philips (ENXTAM:PHIA) announces new collaborations to expand its open monitoring ecosystem and connected care offerings. The company introduces the Philips Avent Share the Care Connector to support …

Koninklijke Philips (ENXTAM:PHIA) Following Exor Stake Update Still Looks Close To Fair Value

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Koninklijke Philips (ENXTAM:PHIA) has drawn renewed attention after updating its long-term agreement with Exor. The move allows Exor to raise its shareholding to 22%, while existing governance …

PHG main company
Sharemaestro market context Price above Trend Line 52 weeks +18.8% · Next-week setup negative 40.9% PHG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Top Research Reports for Meta, Texas Instruments & CrowdStrike

Tuesday, August 11, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Texas Instruments Inc. (TXN) and CrowdStrike Holdings, Inc. (CRWD), as well …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Medtronic (MDT) Wins Analyst Upgrades, Is It Fully Priced?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic (MDT) has moved back into focus after multiple analyst upgrades tied to what they describe as the company's strongest annual revenue growth …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott tells Proactive's Stephen Gunnion that the Icaco 3 well has confirmed up to four hydrocarbon-bearing zones in the Icaco extension of the Tapir Block in Colombia, opening almost 10 additional development locations across the Ubaque, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Versa Vascular Appoints Bill Shields as Chief Executive Officer

Company Expands Series C Financing to $42M SANTA CRUZ, Calif., August 11, 2026--(BUSINESS WIRE)--Versa Vascular, Inc., a pioneering medical device company dedicated to transforming tricuspid valve disease treatment, announced the appointment of Bill Shields as Chief Executive Officer. Former Versa CEO David Hovda is …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?

AbbVie (NYSE: ABBV) is aiming high with its $10.6 billion planned purchase of Apogee Therapeutics (NASDAQ: APGE). The deal, pending regulatory approvals, is expected to close in the third quarter. The move is designed to supplement the pharmaceutical giant's already strong immunology portfolio. However, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players

Company Logo Pulsed Field Ablation MarketPulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Royal Philips And Exor Update Long-Term Relationship Agreement

(RTTNews) - Royal Philips (PHG), a health technology company, and Exor N.V., an investment company, announced that they have agreed to update their long-term relationship agreement. Royal Philips provides image-guided therapy, diagnostic imaging, ultrasound, monitoring, and enterprise informatics and made approximately 18 billion euros …

PHG main company
Sharemaestro market context Price above Trend Line 52 weeks +18.8% · Next-week setup negative 40.9% PHG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

ABT main company MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts' average estimate of around $25.05 billion. Adjusted earnings per share reached $2.90, also exceeding estimates of $2.85. The …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

In the latest close session, Medtronic (MDT) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%. The medical device company's stock has climbed by …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Holdings, Inc. The BACKBEAT global pivotal trial ("BACKBEAT Trial"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?

Abbott Laboratories' ABT Medical Devices remains its largest segment and continues to benefit from a strong pipeline of new product launches and growing adoption across cardiovascular care and diabetes management. The segment is well positioned to capitalize on the expanding global medical devices market. …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?

Intuitive Surgical ISRG currently trades at a forward 12-month P/E ratio of 33.02X, above the Medical - Instruments industry's 26.53X, underscoring a valuation premium that investors must weigh against the company's growth prospects. The stock carries a Value Score of D, suggesting that shares …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

We Said These 4 Dividend Aristocrats Could Soar. Here’s How They Did, Plus 3 New Picks.

Quick Read ABBV surged 47% and BDX gained 26% over the past year, both decisively beating the market as their overlooked dividend growth drove outsized returns. All four original picks kept raising dividends regardless of price, with PG marking its 70th consecutive year of …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

VAREX IMAGING (VREX) Q3 Earnings Beat Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Medtronic (MDT) Becoming a Turnaround Story?

UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a "turnaround" is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Key Points Medtronic has launched new devices that will help further improve its financial results. Intuitive Surgical's latest da Vinci system could expand its addressable market. Each stock will appeal to investors with different priorities. 10 stocks we like better than Medtronic › Medtronic(NYSE: …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech

Key Points Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally. Medical device competitors Medtronic and Johnson & Johnson are bringing out their own surgical robots. Intuitive Surgical's largest revenue source isn't the sale of new da Vinci systems.10 …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.2% · Next-week setup positive 57.9% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories buyback update Abbott Laboratories (ABT) has completed a share repurchase tranche that saw the company buy back 14,015,097 shares for about …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.6% · Next-week setup positive 57.3% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context